Blog

Regular posts covering guidance changes, inspection findings, data methodology, and Redica product updates.

Open filters
Search
Tags
Author
Alison Sathe
Anders Vinther
Barbara W. Unger
Jackie Torfin
Jerry Chapman
Jon Falker
Katie Terry
Mark Agostino
Rebecca Stauffer
Redica Systems
Roger Angarita
Sarah Boynton
Scott Sherrill
Subscribe to our Newsletter
Regular posts covering guidance changes, inspection findings, data methodology, and Redica product updates.
Enforcement

Warning Letters Week of 8/30/2020: Adulterated Products

No items found.
Enforcement

Warning Letters Week Of 8/23/2020: Sterility Assurance Failures

No items found.

Redica Systems Welcomes Aboard Rebecca Stauffer

No items found.
Conference Spotlight

What a Scuba Diving Incident Can Teach Pharma About Quality Systems

No items found.

On-Demand Webinar | Pandemic Impact on Data Integrity Trends

No items found.
Conference Spotlight

How Would FDA Grade Your Site? The Quality Metrics Feedback Program

No items found.
Enforcement

Enforcement Spotlight: Retests Prove Key Data Integrity Concern

No items found.
Enforcement

Warning Letters 07/26/20: Testing into Compliance

No items found.
Enforcement

Warning Letters Week of 07/19/20: Unapproved New Devices

No items found.
Conference Spotlight

Hosting a Virtual FDA Inspection: Advice from Former FDA Investigator and Investigations Director Ricki Chase

No items found.
Conference Spotlight

Preparing for a Virtual FDA Inspection: Advice from Former FDA Investigator and Investigations Director Ricki Chase

No items found.
Enforcement

Warning Letters Week of 07/05/20: Supplier Qualification

No items found.
Conference Spotlight

A State-of-the-Art Virtual Inspection Methodology Using Mixed Reality Technology Gets High Marks from European Medicines Agency Inspector

No items found.
Enforcement

Warning Letters 06/28/20: Unapproved Vendors

No items found.
Conference Spotlight

Yes, FDA is Still Performing Pharma Inspections, Using Risk-Based Criteria: What is Your Risk for Inspection?

No items found.
Enforcement

FDA Warning Letters Week of 06/21/20: For-Cause Inspection & Untitled Letter From A 2018 Inspection

No items found.
Conference Spotlight

Microbiological Issues with Aseptic Processing and Lyophilization: CGMP Inspection Case Study by FDA National Drug Expert Ileana Barreto-Pettit

No items found.
Enforcement

Warning Letters Week of 06/14/20: Data Integrity

No items found.